BlackRock, Inc. 13D and 13G filings for Beam Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Beam Therapeutics Inc. BEAM |
BlackRock Inc. BLK |
7,499,930 7.500% |
-248,347 (-3.21%) |
Filing |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Beam Therapeutics Inc. BEAM |
BlackRock Inc. BLK |
7,748,277 9.400% |
0 (Unchanged) |
Filing |
| 2024-10-21 4:11 pm Purchase |
2024-09-30 | 13G | Beam Therapeutics Inc. BEAM |
BlackRock Inc. BLK |
7,748,277 9.400% |
1,086,234 (+16.30%) |
Filing |
| 2024-01-25 4:59 pm Purchase |
2023-12-31 | 13G | Beam Therapeutics Inc. BEAM |
BlackRock Inc. BLK |
6,662,043 8.200% |
1,423,763 (+27.18%) |
Filing |
| 2023-02-02 4:05 pm Purchase |
2022-12-31 | 13G | Beam Therapeutics Inc. BEAM |
BlackRock Inc. BLK |
5,238,280 7.400% |
1,175,486 (+28.93%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Beam Therapeutics Inc. BEAM |
BlackRock Inc. BLK |
4,062,794 6.000% |
970,983 (+31.40%) |
Filing |
| 2021-04-09 6:02 pm Sale |
2021-03-31 | 13G | Beam Therapeutics Inc. BEAM |
BlackRock Inc. BLK |
3,091,811 5.000% |
-67,699 (-2.14%) |
Filing |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Beam Therapeutics Inc. BEAM |
BlackRock Inc. BLK |
3,159,510 5.500% |
3,159,510 (New Position) |
Filing |